AirDuo Digihaler 232/14 Inhalation Powder Recall for Subpotent Salmeterol
Teva Pharmaceuticals is recalling approximately 5,500 units of AirDuo Digihaler 232/14 inhalation powder distributed nationwide because some inhalers contain less salmeterol than the labeled dose.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall involving a subpotent drug with out-of-specification results. The source text does not report any hospitalizations, illnesses, or injuries, and the hazard is the risk of underdosing rather than contamination or acute harm. Class II recalls without reported adverse events typically warrant a Moderate severity score.
Plain-English summary
Teva Pharmaceuticals USA is recalling AirDuo Digihaler 232/14 (fluticasone propionate 232 mcg and salmeterol 14 mcg) Inhalation Powder with code AFR18A. The recall was initiated because out-of-specification test results showed that some inhalers emitted less salmeterol than the label claimed.
Approximately 5,500 inhalers were distributed nationwide. The product is a prescription-only asthma and COPD medication manufactured in Ireland by Teva Respiratory, LLC (Frazer, PA).
Patients currently using affected inhalers should contact their healthcare provider or pharmacist immediately. Do not abruptly stop using the medication without medical guidance, as this could worsen respiratory symptoms. Consult a healthcare professional about whether your supply is affected and what steps to take next.
The recalled product
- Product
- AirDuo Digihaler 232/14 (fluticasone propionate 232 mcg and salmeterol 14 mcg) Inhalation Powder, Rx Only, Mktd by: Teva Respiratory, LLC, Frazer, PA 19355, Manufactured in Ireland, NDC 59310-136-06
- Manufacturer
- Teva Pharmaceuticals USA
- Category
- Drug — Respiratory / Asthma-COPD
- Hazard
- subpotent-drug
- underdose
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- AFR18A
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27